Literature DB >> 25341799

Loss of β-catenin promotes chondrogenic differentiation of aortic valve interstitial cells.

Ming Fang1, Christina M Alfieri1, Alexia Hulin1, Simon J Conway1, Katherine E Yutzey2.   

Abstract

OBJECTIVE: The Wnt/β-catenin signaling pathway has been implicated in human heart valve disease and is required for early heart valve formation in mouse and zebrafish. However, the specific functions of Wnt/β-catenin signaling activity in heart valve maturation and maintenance in adults have not been determined previously. APPROACH AND
RESULTS: Here, we show that Wnt/β-catenin signaling inhibits Sox9 nuclear localization and proteoglycan expression in cultured chicken embryo aortic valves. Loss of β-catenin in vivo in mice, using Periostin(Postn)Cre-mediated tissue-restricted loss of β-catenin (Ctnnb1) in valvular interstitial cells, leads to the formation of aberrant chondrogenic nodules and induction of chondrogenic gene expression in adult aortic valves. These nodular cells strongly express nuclear Sox9 and Sox9 downstream chondrogenic extracellular matrix genes, including Aggrecan, Col2a1, and Col10a1. Excessive chondrogenic proteoglycan accumulation and disruption of stratified extracellular matrix maintenance in the aortic valve leaflets are characteristics of myxomatous valve disease. Both in vitro and in vivo data demonstrate that the loss of Wnt/β-catenin signaling leads to increased nuclear expression of Sox9 concomitant with induced expression of chondrogenic extracellular matrix proteins.
CONCLUSIONS: β-Catenin limits Sox9 nuclear localization and inhibits chondrogenic differentiation during valve development and in adult aortic valve homeostasis.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  Wnt signaling pathway; aortic valve; chondrogenesis; heart valve disease; proteoglycans

Mesh:

Substances:

Year:  2014        PMID: 25341799      PMCID: PMC4239156          DOI: 10.1161/ATVBAHA.114.304579

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  48 in total

1.  Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation.

Authors:  Frank C Caira; Stuart R Stock; Thomas G Gleason; Edwin C McGee; Jie Huang; Robert O Bonow; Thomas C Spelsberg; Patrick M McCarthy; Shahbudin H Rahimtoola; Nalini M Rajamannan
Journal:  J Am Coll Cardiol       Date:  2006-03-20       Impact factor: 24.094

Review 2.  The role of TGFbetas and Sox9 during limb chondrogenesis.

Authors:  Yasuhiko Kawakami; Joaquín Rodriguez-León; Juan Carlos Izpisúa Belmonte
Journal:  Curr Opin Cell Biol       Date:  2006-10-16       Impact factor: 8.382

Review 3.  Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development.

Authors:  Joy Lincoln; Alexander W Lange; Katherine E Yutzey
Journal:  Dev Biol       Date:  2006-04-27       Impact factor: 3.582

4.  Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy.

Authors:  Florence Kyndt; Jean-Pierre Gueffet; Vincent Probst; Philippe Jaafar; Antoine Legendre; Françoise Le Bouffant; Claire Toquet; Estelle Roy; Lesley McGregor; Sally Ann Lynch; Ruth Newbury-Ecob; Vinh Tran; Ian Young; Jean-Noel Trochu; Hervé Le Marec; Jean-Jacques Schott
Journal:  Circulation       Date:  2006-12-26       Impact factor: 29.690

5.  New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies.

Authors:  Francesca Nesta; Maire Leyne; Chaim Yosefy; Charles Simpson; Daisy Dai; Jane E Marshall; Judy Hung; Susan A Slaugenhaupt; Robert A Levine
Journal:  Circulation       Date:  2005-09-19       Impact factor: 29.690

6.  Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development.

Authors:  Joy Lincoln; Ralf Kist; Gerd Scherer; Katherine E Yutzey
Journal:  Dev Biol       Date:  2007-02-07       Impact factor: 3.582

7.  Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart.

Authors:  Paige Snider; Robert B Hinton; Ricardo A Moreno-Rodriguez; Jian Wang; Rhonda Rogers; Andrew Lindsley; Fang Li; David A Ingram; Donald Menick; Loren Field; Anthony B Firulli; Jeffery D Molkentin; Roger Markwald; Simon J Conway
Journal:  Circ Res       Date:  2008-02-22       Impact factor: 17.367

Review 8.  Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice.

Authors:  Tamara Grigoryan; Peter Wend; Alexandra Klaus; Walter Birchmeier
Journal:  Genes Dev       Date:  2008-09-01       Impact factor: 11.361

9.  Opposing actions of Notch1 and VEGF in post-natal cardiac valve endothelial cells.

Authors:  Jeong-Hee Yang; Jill Wylie-Sears; Joyce Bischoff
Journal:  Biochem Biophys Res Commun       Date:  2008-07-21       Impact factor: 3.575

10.  Identification and characterization of a novel Schwann and outflow tract endocardial cushion lineage-restricted periostin enhancer.

Authors:  Andrew Lindsley; Paige Snider; Hongming Zhou; Rhonda Rogers; Jian Wang; Michael Olaopa; Agnieszka Kruzynska-Frejtag; Shrinagesh V Koushik; Brenda Lilly; John B E Burch; Anthony B Firulli; Simon J Conway
Journal:  Dev Biol       Date:  2007-05-03       Impact factor: 3.582

View more
  24 in total

1.  Non-pathological Chondrogenic Features of Valve Interstitial Cells in Normal Adult Zebrafish.

Authors:  Alina Schulz; Jana Brendler; Orest Blaschuk; Kathrin Landgraf; Martin Krueger; Albert M Ricken
Journal:  J Histochem Cytochem       Date:  2019-01-08       Impact factor: 2.479

2.  Increased canonical WNT/β-catenin signalling and myxomatous valve disease.

Authors:  Sunita Chopra; Nadia Al-Sammarraie; Yimu Lai; Mohamad Azhar
Journal:  Cardiovasc Res       Date:  2017-01       Impact factor: 10.787

3.  Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.

Authors:  Alexia Hulin; Vicky Moore; Jeanne M James; Katherine E Yutzey
Journal:  Cardiovasc Res       Date:  2016-11-07       Impact factor: 10.787

4.  Hypoxia promotes primitive glycosaminoglycan-rich extracellular matrix composition in developing heart valves.

Authors:  Dorothy Amofa; Alexia Hulin; Yuji Nakada; Hesham A Sadek; Katherine E Yutzey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-25       Impact factor: 4.733

5.  Strontium ranelate promotes chondrogenesis through inhibition of the Wnt/β-catenin pathway.

Authors:  Hao Yu; Yan Liu; Xiangwen Yang; Jiajing He; Fan Zhang; Qun Zhong; Xiaojing Guo
Journal:  Stem Cell Res Ther       Date:  2021-05-20       Impact factor: 6.832

6.  Analysis of -5p and -3p Strands of miR-145 and miR-140 During Mesenchymal Stem Cell Chondrogenic Differentiation.

Authors:  Jonathan D Kenyon; Olga Sergeeva; Rodrigo A Somoza; Ming Li; Arnold I Caplan; Ahmad M Khalil; Zhenghong Lee
Journal:  Tissue Eng Part A       Date:  2018-05-24       Impact factor: 3.845

7.  Wnt/β-catenin signaling enables developmental transitions during valvulogenesis.

Authors:  Fernanda M Bosada; Vidusha Devasthali; Kimberly A Jones; Kryn Stankunas
Journal:  Development       Date:  2016-02-18       Impact factor: 6.868

8.  Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification.

Authors:  M Victoria Gomez-Stallons; Elaine E Wirrig-Schwendeman; Keira R Hassel; Simon J Conway; Katherine E Yutzey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-05-19       Impact factor: 8.311

Review 9.  Genetic tools for identifying and manipulating fibroblasts in the mouse.

Authors:  Jessica M Swonger; Jocelyn S Liu; Malina J Ivey; Michelle D Tallquist
Journal:  Differentiation       Date:  2016-06-21       Impact factor: 3.880

Review 10.  Aggrecan in Cardiovascular Development and Disease.

Authors:  Christopher D Koch; Chan Mi Lee; Suneel S Apte
Journal:  J Histochem Cytochem       Date:  2020-09-01       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.